Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02276170 · ClinicalTrials.gov registry record
Pharmacology of Aminophylline for Acute Kidney Injury in Neonates
A clinical trial, sponsored by Stanford University.
- Terminated
- Registry status
- 9
- Enrollment target
NCT02276170: Clinical Trial study, sponsored by Stanford University.
NCT02276170 is a clinical trial that was terminated before completion, run by Stanford University. The registered enrollment target is 9 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02276170 was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- 9 participants
- Enrollment target
Study Summary
Acute kidney injury (AKI) in critically ill neonates is common and associated with significant morbidity and mortality. No targeted therapeutic treatment strategies have been established for AKI in neonates. Within a clinical pharmacokinetic and pharmacodynamic conceptual framework, this project will examine the medication aminophylline as a potential treatment approach for AKI.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2014-10 |
| Est. Completion | 2018-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02276170
The ClinicalTrials.gov registry entry for NCT02276170 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02276170 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02276170 about?
NCT02276170 is a clinical study titled "Pharmacology of Aminophylline for Acute Kidney Injury in Neonates". Acute kidney injury (AKI) in critically ill neonates is common and associated with significant morbidity and mortality. No targeted therapeutic treatment strategies have been established for AKI in neonates. Within a clinical pharmacokinetic and pharmacodynamic conceptual framework, this project wil...
What is the current status of trial NCT02276170?
This trial is currently terminated. The enrollment target is 9 participants. The study started on 2014-10. Estimated completion is 2018-08.
Who is sponsoring clinical trial NCT02276170?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.